NCT00003632View on ClinicalTrials.gov

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 1998

Primary Completion Date

July 31, 2005

Conditions
Lymphoma
Interventions
BIOLOGICAL

filgrastim

DRUG

carmustine

DRUG

cytarabine

DRUG

etoposide

DRUG

melphalan

DRUG

methotrexate

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003632 - Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Central Nervous System Lymphoma | Biotech Hunter | Biotech Hunter